Reuters logo
4 个月前
BRIEF-Rigel announces Q1 loss per share $0.13
2017年5月2日 / 晚上8点53分 / 4 个月前

BRIEF-Rigel announces Q1 loss per share $0.13

May 2 (Reuters) - Rigel Pharmaceuticals Inc

* Rigel announces first quarter 2017 financial results and provides company update

* Q1 loss per share $0.13

* Q1 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S

* Rigel Pharmaceuticals Inc - As of March 31, 2017, Rigel had cash, cash equivalents and short-term investments of $98.1 million

* Rigel Pharmaceuticals-Expects cash, cash equivalents and short-term investments to be sufficient to support current and projected funding requirements

* Rigel Pharmaceuticals - Is selecting a molecule from its irak program for preclinical development

* Rigel Pharmaceuticals-Expected that irak program development will include clinical evaluation in immunology areas, such as for lupus, gout and/or psoriasis

* Rigel Pharmaceuticals Inc qtrly contract revenues from collaborations $3.6 million versus $5.0 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below